Skip to main content

Day: June 28, 2022

Egide: Closing of a Sale/Lease back of the Cambridge building for $6m

Bollène, June 28, 2022 – 06:00 pm (CET) Press ReleaseFor immediate release CLOSING OF THE SALE/LEASE-BACK OF THE BUILDING IN CAMBRIDGE (MD, USA) FOR $6M Egide Group announces the closing with Tempus Cambridge LLC (Arkansas, USA) and Egide USA Inc. (MD, USA) of a Sale/Lease back of the Cambridge building for $6m. The lease attached to the deal is signed for 15 years with a $0.4m annual lease. This financing agreement will allow to reduce considerably the US debt, facilitate the negotiation of new revolving lines in replacement of existing lines of credit. The Egide Group will benefit from this a cash infusion favorable for both the working capital and to sustainably finance capex to modernize the facilities both in Cambridge and in San Diego facilities. Jim Collins, President and CEO, said, “We are very pleased today to announce...

Continue reading

GROUPE PARTOUCHE: Income 1st Half-Year 2021/2022 – Solid 1st HY Income and resumption of growth investments

Income 1st Half-Year 2021/2022Solid 1st HY Incomeand resumption of growth investmentsTurnover: € 187.2 M (x4,0) EBITDA: € 34.2 M compared to – € 42.0 M at 1st HY 2021 Net Income: € 24.6 M compared to – € 88.0 M at 1st HY 2021 Healthy financial situation: gearing of 0.2x and leverage of 0.7xParis, 28th June 2022, 06:00 p.m. During its meeting held on the 28th June 2022 and after having reviewed the management report of Groupe Partouche Executive Board, the Supervisory Board examined the 1st Half-Year of financial year 2021-2022 (November 2021 to April 2022). Good operational performance driven by the gradual normalization of activity In a context of a gradual return to usual casino operations, the operating performance for the 1st half of 2022 improves significantly compared to the 1st half of the previous financial year....

Continue reading

Life Cycle Analysis Confirms Environmental Superiority of CoalSwitch® Reduces CO2 Emissions by 99% Relative to Coal and 97% Relative to Natural Gas

As a “drop-in” feedstock, CoalSwitch can instantly help power plants and other industries that rely on coal-fired boilers reduce emissions associated with use ASHLAND, Maine, June 28, 2022 (GLOBE NEWSWIRE) — A Life Cycle Assessment of CoalSwitch®, shows the pellet made from lumbermill waste by Active Energy Group (AIM:AEG), reduces CO2 emissions by 99 percent relative to coal and 97 percent relative to natural gas. The report was produced by Life Cycle Associates, an independent business and environmental consulting firm, based in California, specializing in life cycle analysis of fuel production pathways. “This Life Cycle Associates analysis provides significant independent confirmation of the reduced greenhouse gas emissions incurred in the production of CoalSwitch®,” said Michael Rowan, CEO of Active Energy Group. “These conclusions...

Continue reading

ICG Enterprise Trust Plc: Results of 2022 Annual General Meeting

ICG Enterprise Trust plc (the “Company”) 28 June 2022 Results of 2022 Annual General Meeting The Company announces that at its Annual General Meeting (“AGM”) held this afternoon, all resolutions proposed were duly passed by the requisite majority the details of which are set out in the table below:RESOLUTION VOTES FOR % FOR VOTES AGAINST % AGAINST VOTES TOTAL % OF ISC VOTED VOTES WITHHELD1. To receive and adopt the reports of the directors and auditors and the Company’s financial statements. 22,069,842 97.73 512,610 2.27 22,582,452 32.96% 47,7722. To declare a final dividend. 22,571,096 99.97 6,312 0.03 22,577,408 32.95% 52,8163. To re-elect J. Tufnell as a director. 20,675,427 91.69 1,874,064 8.31 22,549,491 32.91% 80,7334. To re-elect A. Bruce as a director. 22,282,669 98.85 259,957 1.15 22,542,626 32.90% 87,5985. To...

Continue reading

Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley

CHARLOTTESVILLE, Va., June 28, 2022 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today issued the following letter to its shareholders from the Company’s CEO, William Stilley. Dear Shareholders, It continues to be my great honor to serve you as CEO of Adial Pharmaceuticals, especially at this momentous time when you and I, anxiously yet optimistically, await top-line results from the ONWARD™ Phase 3 clinical trial. Yesterday, we announced database lock for ONWARD, and today, I want to take this opportunity to personally write to you. Great care was taken to verify and validate the integrity of all data collected during ONWARD, all of which remained blinded throughout. Now that database lock is complete, meaning the dataset has been permanently set, the data has been transferred...

Continue reading

Albioma : Presentation of 2022 first-half results

Presentation of 2022 first-half results Frédéric Moyne, Chairman & CEO of Albioma, and Julien Gauthier, Deputy CEO – Finance, are pleased to invite you to attend a conference call organised on 26 July 2022, at 6:00 pm (CET), to present the results of the first half of the 2022 financial year. The presentation will be in French, a simultaneous translation into English will be provided. You are kindly invited to dial in using one of the following numbers. France:                   +33 (0)1 76 77 28 19 United Kingdom:        +44 (0)330 165 4012 Brazil:                     +55 11 3181 5422 Confirmation code:      6337772 To follow the online presentation, join the webcast using this link:https://globalmeet.webcasts.com/starthere.jsp?ei=1557050&tp_key=02bad5e876  AttachmentAlbioma_Invitation_conference_analystes_20220726_ENG ...

Continue reading

Workplace Options acquires Essi Systems’ stress, resiliency and emotional intelligence assessments and behavior change tools to enhance its digital wellbeing solutions offerings

RALEIGH, N.C., June 28, 2022 (GLOBE NEWSWIRE) — Workplace Options, a leading provider of integrated global wellbeing solutions, announced that it acquired Essi Systems’ stress, resiliency and emotional intelligence assessments and behavior change tools. Essi Systems is an international management consulting company that has been delivering scalable human capital solutions to improve employee health and optimize performance to more than 4,000 organizations in thirty countries worldwide for over 35 years. “This acquisition will strengthen Workplace Options’ suite of digital services, adding new tools to our suite of emotional, practical, and physical solutions,” says Alan King, President, and CEO at Workplace Options. “Our clients will benefit from the assessments and behavioral change tools that Essi Systems developed to further...

Continue reading

Tristan Tahmaseb Announced as Recipient of The M&A Advisor’s 13th Annual Emerging Leaders Awards

ST. LOUIS, June 28, 2022 (GLOBE NEWSWIRE) — Saint Louis, MO, June 2022 –The M&A Advisor announced Tristan Tahmaseb, Senior Associate, ButcherJoseph & Co., as one of the recipients of the 13th Annual Emerging Leaders Awards.   The M&A Advisor, renowned globally for its recognition and presentation of leading M&A, financing, and turnaround professionals, created this recognition awards program to promote mentorship and professional development amongst the emerging leaders of corporate finance and dealmaking industries.  Tristan has been chosen from a pool of prominent nominees for his notable accomplishments in business and in service to the community.  Evaluation and selection of the nominees was completed by an independent judging panel.  “The Emerging Leaders Awards were born as the ‘40 Under 40 Awards’...

Continue reading

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient Yardley, PA, June 28, 2022 (GLOBE NEWSWIRE) — Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance—have announced an agreement to merge the companies. By uniting Norstella, which is comprised of four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—with Citeline, the combined company will be well positioned to help life sciences companies reach patients faster by providing clients with the intelligence...

Continue reading

BBS-Bioactive Bone Substitutes Plc: Trading on BBS’s warrants begins on First North Growth Market Finland

BBS-Bioactive Bone Substitutes Plc   Company Announcement 28 June 2022 17.00 (CEST) Trading on warrants 1-2022 (TO1) ja 2-2022 (TO2) issued by BBS-Bioactive Bone Substitutes Plc (“BBS” or the “Company”) begins on First North Growth Market Finland approximately on 1 July 2022. Since only 8,084 warrants of series 1-2022 (TO1) and 2-2022 (TO2) each were subscribed in Sweden by a total of 199 subscribers, the warrants will not be subject to trading on First North Growth Market Sweden. BBS will provide the investors who have subscribed for warrants in Sweden and whose warrants have been delivered through the book-entry system maintained by Euroclear Sweden AB instructions on how to convert their warrants into warrants that are in the book-entry system maintained by Euroclear Finland Oy which can be traded on First North Growth Market Finland....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.